A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation is a research paper published in Nature Chemical Biology (2024). On theSindex it has a DataRank of 1.2. It has been cited 51 times, with 44 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.593
From this paper's citation signal
Citation Network Contribution
0.621
From 34 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 44 citers.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R00CA248715
Damon Runyon Cancer Research Foundation
Grant: DFS-53-22
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Grant: T32GM105538
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Grant: T32GM149439
National Institutes of Health
Grant: 1T32GM105538-01
Chemistry of Life Processes Predoctoral Training Program
National Institutes of Health
Grant: 5T32GM149439-03
Chemistry of Life Processes Predoctoral Training Program
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 5R00CA248715-05
Discovery of small molecule-mediated protein degradation pathways in human cancer
National Science Foundation
Fields of Study
MeSH Terms
Keywords